Evidence map›Paper›PMID 29758005›Full record

ReviewViruses2018

A Review of the Ongoing Research on Zika Virus Treatment.

Suely da Silva, Daniel Oliveira Silva Martins, Ana Carolina Gomes Jardim

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Industrial crops and products · 2020
    Article
  12. siRNA Design to Silence the 3'UTR Region of Zika Virus.BioMed research international · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Frontiers in cellular and infection microbiology · 2019
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Suely da SilvaLaboratory of Virology, Institute of Biomedical Science, ICBIM, Federal University of Uberlândia, Uberlândia, MG 38405-302, Brazil. suelysilva0712@hotmail.com.
Daniel Oliveira Silva MartinsLaboratory of Virology, Institute of Biomedical Science, ICBIM, Federal University of Uberlândia, Uberlândia, MG 38405-302, Brazil. danielosmartins@gmail.com.
Ana Carolina Gomes JardimLaboratory of Virology, Institute of Biomedical Science, ICBIM, Federal University of Uberlândia, Uberlândia, MG 38405-302, Brazil. jardim@ufu.br.
Universidade Federal de Uberlândia · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Zika fever is an arboviral disease resulting from the infection with Zika virus (ZIKV). The virus is transmitted to humans by the bite of

Indexed as

AedesAmericasAnimalsAntiviral AgentsBiomedical ResearchDisease OutbreaksHumansMicrocephalyMosquito VectorsPublic HealthSalivaZika VirusZika Virus InfectionAntiviral Agentsantiviralscreen of drugstreatmentZika feverZIKV

Identifiers

PMID29758005
PMCPMC5977248
OpenAlexW2800954542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.